{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:32:57Z","timestamp":1793946777115,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD021785"],"award-info":[{"award-number":["S10OD021785"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025154","name":"University of Sadat City","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["5R01EY026635"],"award-info":[{"award-number":["5R01EY026635"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jconrel.2026.114890","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:24:12Z","timestamp":1774970652000},"page":"114890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["AI-validated fusion proteins for local inhibition of interleukin-17A"],"prefix":"10.1016","volume":"394","author":[{"given":"Shin-Jae","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quratulain","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Aly","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley D.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Edman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah F.","family":"Hamm-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"MacKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jconrel.2026.114890_bb0005","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114890_bb0010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/prd.12083","article-title":"Basic biology and role of interleukin-17 in immunity and inflammation","volume":"69","author":"Zenobia","year":"2015","journal-title":"Periodontol"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114890_bb0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The IL-17 family in diseases: from bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114890_bb0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/ni.2093","article-title":"IL-17R signaling: new players get in on the act1","volume":"12","author":"May","year":"2011","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114890_bb0025","doi-asserted-by":"crossref","DOI":"10.4110\/in.2022.22.e8","article-title":"Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research","volume":"22","author":"Kim","year":"2022","journal-title":"Immune Netw."},{"issue":"12","key":"10.1016\/j.jconrel.2026.114890_bb0030","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1128\/IAI.00596-16","article-title":"Interleukin-17A (IL-17A) and IL-17F are critical for antimicrobial peptide production and clearance of staphylococcus aureus nasal colonization","volume":"84","author":"Archer","year":"2016","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114890_bb0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12079-022-00686-y","article-title":"A comprehensive network map of IL-17A signaling pathway","volume":"17","author":"Rex","year":"2023","journal-title":"J. Cell Commun. Signal."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114890_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062505","article-title":"The role of IL-17A in mediating inflammatory responses and progression of neurodegenerative diseases","volume":"26","author":"Zheng","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.114890_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.572858","article-title":"Th17\/Treg-Related Transcriptional Factor Expression and Cytokine Profile in Patients With Rheumatoid Arthritis","volume":"11","author":"Paradowska-Gorycka","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114890_bb0050","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory t cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jconrel.2026.114890_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1005115","article-title":"The imbalance between type 17 t-cells and regulatory immune cell subsets in psoriasis vulgaris","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114890_bb0065","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41584-023-01057-6","article-title":"Epidemiology of sj\u00f6gren syndrome","volume":"20","author":"Beydon","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2026.114890_bb0070","doi-asserted-by":"crossref","unstructured":"X. Chen et al., \u201cElevated cytokine levels in tears and saliva of patients with primary sj\u00f6grens syndrome correlate with clinical ocular and oral manifestations,\u201d Sci. Rep., vol. 9, no. 1, Art. no. 1, May 2019, doi:https:\/\/doi.org\/10.1038\/s41598-019-43714-5.","DOI":"10.1038\/s41598-019-43714-5"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114890_bb0075","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajo.2013.04.003","article-title":"Analysis of Tear Cytokines and Clinical Correlations in Sj\u00f6gren Syndrome Dry Eye Patients and Non\u2013Sj\u00f6gren Syndrome Dry Eye Patients","volume":"156","author":"Lee","year":"2013","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114890_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1277","article-title":"IL-17 drives salivary gland dysfunction via inhibiting TRPC1-mediated calcium movement in sj\u00f6grens syndrome","volume":"10","author":"Xiao","year":"2021","journal-title":"Clin. Transl. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114890_bb0085","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/art.23214","article-title":"Salivary gland tissue expression of interleukin-23 and interleukin-17 in sj\u00f6grens syndrome: findings in humans and mice","volume":"58","author":"Nguyen","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114890_bb0090","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis \u2014 results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.jconrel.2026.114890_bb0095","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa1503824","article-title":"Phase 3 studies comparing brodalumab with ustekinumab in psoriasis","volume":"373","author":"Lebwohl","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114890_bb0100","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/annrheumdis-2017-212687","article-title":"Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study","volume":"77","author":"Mease","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114890_bb0105","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/annrheumdis-2016-209730","article-title":"Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study","volume":"76","author":"Braun","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2026.114890_bb0110","article-title":"Risk of candidiasis associated with interleukin-17 inhibitors: a real-world observational study of multiple independent sources","volume":"13","author":"Davidson","year":"2022","journal-title":"Lancet Reg. Health \u2013 Eur."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114890_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2442603","article-title":"Risk of candida infection and serious infections in patients with moderate-to-severe psoriasis receiving biologics: a systematic review and meta-analysis of randomized controlled trials","volume":"2022","author":"Feng","year":"2022","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114890_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bjd.15015","article-title":"Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management","volume":"177","author":"Saunte","year":"2017","journal-title":"Br. J. Dermatol"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114890_bb0125","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/s41598-023-50013-7","article-title":"Assessment of safety profile of secukinumab in real-world scenario using United States food and drug administration adverse event reporting system database","volume":"14","author":"Eshwar","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114890_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0972-124X.94603","article-title":"A comparative evaluation of atrigel delivery system (10% doxycycline hyclate) atridox with scaling and root planing and combination therapy in treatment of periodontitis: a clinical study","volume":"16","author":"Javali","year":"2012","journal-title":"J. Indian Soc. Periodontol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114890_bb0140","first-page":"307","article-title":"Otiprio: An FDA-approved ciprofloxacin suspension gel for pediatric otitis media with effusion","volume":"42","author":"Edmunds","year":"2017","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.jconrel.2026.114890_bb0145","author":"Immunoforge Co. Ltd"},{"issue":"9","key":"10.1016\/j.jconrel.2026.114890_bb0150","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1021\/acs.biomac.4c00165","article-title":"Development of an elastin-like polypeptide-based nucleic acid delivery system targeted to EGFR+ bladder cancer cells using a layer-by-layer approach","volume":"25","author":"Aayush","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.114890_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114589","article-title":"Emerging opportunities in bioconjugates of elastin-like polypeptides with synthetic or natural polymers","volume":"191","author":"Garanger","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114890_bb0160","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/acs.molpharmaceut.6b01021","article-title":"An anti-programmed death-1 antibody (\u03b1PD-1) fusion protein that self-assembles into a multivalent and functional \u03b1PD-1 nanoparticle","volume":"14","author":"Zhao","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114890_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115496","article-title":"Elastin-like polypeptide delivery of an NF-kB inhibitor for treatment of juvenile mild TBI complicated by high-fat diet consumption","volume":"395","author":"Haskell","year":"2026","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114890_bb0170","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mabi.201400419","article-title":"Elastin-like polypeptide based nanoparticles: design rationale toward nanomedicine","volume":"15","author":"Smits","year":"2015","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2026.114890_bb0175","doi-asserted-by":"crossref","unstructured":"S. Liu et al., \u201cInhibiting complex IL-17A and IL-17RA interactions with a linear peptide,\u201d Sci. Rep., vol. 6, no. 1, Art. no. 1, May 2016, doi:https:\/\/doi.org\/10.1038\/srep26071.","DOI":"10.2210\/pdb5hhx\/pdb"},{"issue":"8016","key":"10.1016\/j.jconrel.2026.114890_bb0180","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114890_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001962","article-title":"AlphaFold2-multimer guided high-accuracy prediction of typical and atypical ATG8-binding motifs","volume":"21","author":"Ibrahim","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jconrel.2026.114890_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121441","article-title":"Supra-lacrimal protein-based carriers for cyclosporine a reduce th17-mediated autoimmunity in murine model of sj\u00f6grens syndrome","volume":"283","author":"Guo","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114890_bb0195","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jconrel.2020.05.021","article-title":"Anti-FLT3 nanoparticles for acute myeloid leukemia: preclinical pharmacology and pharmacokinetics","volume":"324","author":"Park","year":"2020","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114890_bb0200","doi-asserted-by":"crossref","first-page":"6.11.1","DOI":"10.1002\/0471140864.ps0611s61","article-title":"Elastin-like polypeptides as a purification tag for recombinant proteins","volume":"61","author":"Hassouneh","year":"2010","journal-title":"Curr. Protoc. Protein Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114890_bb0205","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1021\/acs.biomac.9b00503","article-title":"Generation of a monoclonal antibody to detect elastin-like polypeptides","volume":"20","author":"Kouhi","year":"2019","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114890_bb0210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41467-021-27838-9","article-title":"Harnessing protein folding neural networks for peptide\u2013protein docking","volume":"13","author":"Tsaban","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114890_bb0215","article-title":"AF2Complex predicts direct physical interactions in multimeric proteins with deep learning","volume":"13","author":"Gao","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114890_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.643110","article-title":"Tropoelastin and elastin assembly","volume":"9","author":"Ozsvar","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"51","key":"10.1016\/j.jconrel.2026.114890_bb0225","doi-asserted-by":"crossref","first-page":"11007","DOI":"10.1021\/jp972167t","article-title":"Physical chemistry of biological free energy transduction as demonstrated by elastic protein-based polymers","volume":"101","author":"Urry","year":"1997","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jconrel.2026.114890_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.596702","article-title":"Elastin structure, synthesis, regulatory mechanism and relationship with cardiovascular diseases","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114890_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12101817","article-title":"\u0391B-crystallin peptide fused with elastin-like polypeptide: intracellular activity in retinal pigment epithelial cells challenged with oxidative stress","volume":"12","author":"Attia","year":"2023","journal-title":"Antioxidants"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114890_bb0240","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1021\/bm401622y","article-title":"Multimeric disintegrin protein polymer fusions that target tumor vasculature","volume":"15","author":"Janib","year":"2014","journal-title":"Biomacromolecules"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114890_bb0245","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1021\/acs.biomac.7b00686","article-title":"Thermoresponsive elastin- b -collagen-like peptide bioconjugate nanovesicles for targeted drug delivery to collagen-containing matrices","volume":"18","author":"Luo","year":"2017","journal-title":"Biomacromolecules"},{"issue":"16","key":"10.1016\/j.jconrel.2026.114890_bb0250","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1016\/j.cell.2024.05.052","article-title":"Preclinical proof of principle for orally delivered th17 antagonist miniproteins","volume":"187","author":"Berger","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114890_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121755","article-title":"IL-17A-targeting fenofibrate attenuates inflammation in psoriasis by inducing autophagy","volume":"326","author":"Park","year":"2023","journal-title":"Life Sci."},{"issue":"19","key":"10.1016\/j.jconrel.2026.114890_bb0260","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1021\/acschemneuro.5c00519","article-title":"Niraparib demonstrates therapeutic potential in multiple sclerosis through inhibition of IL-17A receptor interaction and promotion of remyelination","volume":"16","author":"Orhan","year":"2025","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114890_bb0265","article-title":"Animal models of C-reactive protein","volume":"2014","author":"Torzewski","year":"2014","journal-title":"Mediat. Inflamm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:10:26Z","timestamp":1793945426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926002920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":51,"alternative-id":["S0168365926002920"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114890","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-validated fusion proteins for local inhibition of interleukin-17A","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114890"}}